[News Brief] KPJ Healthcare and Novo Nordisk Sign Obesity Care Partnership
KPJ Healthcare Berhad and Novo Nordisk Malaysia have signed a Memorandum of Understanding to develop structured, multidisciplinary care for obesity…
Press Release
[News Brief] NUHS Launches Centre for Genomic Medicine
The National University Health System has established the National University Centre for Genomic Medicine to expand the use of genomics…
[News Brief] SGH Uses Simulation Technology for Shoulder Replacements
Surgeons at Singapore General Hospital are using Finite Element analysis to plan shoulder replacement surgeries, enabling pre-operative assessment of implant…
[News Brief] SingHealth Duke-NUS Launches Allergic Diseases Centre
SingHealth and Duke-NUS have established the SingHealth Duke-NUS Allergic Diseases Centre (SDADC) to provide coordinated, multidisciplinary care for patients with…
[News Brief] Singapore Should Aim to Train 10,000 Palliative Care Trainees by 2030
According to Health Minister Ong Ye Kung, Singapore plans to train up to 10,000 nurses and healthcare workers in general…
[News Brief] Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals
Everest Medicines has entered a share purchase agreement to acquire Hasten Biopharmaceuticals (SG) Pte. Ltd., aiming to expand its commercial…
[News Brief] Health365 Adds PhysioVitae Therapists, Records Podcast
Health365 has added two Preferred Physiotherapists from PhysioVitae Singapore and recorded a podcast interview to broaden public understanding of physiotherapy…
[News Brief] UBT251 Phase 2 Trial Shows HbA1c Reduction in Chinese Patients with Type 2 Diabetes
United Biotechnology and Novo Nordisk have reported topline results from a phase 2 trial of UBT251 in Chinese patients with…
[News Brief] Cirrus Therapeutics Expands to Singapore with R&D Site
Cirrus Therapeutics has expanded into Singapore with a new R&D site and formed a partnership with A*STAR to advance ophthalmic…
[News Brief] ImmunoScape Signs MoU for US Cancer Clinical Trial
ImmunoScape has signed a Memorandum of Understanding with a US-based cancer centre to launch an investigator-initiated clinical trial targeting WT1-positive…